High expression of prolactin receptor is associated with cell survival in cervical cancer cells (original) (raw)

A 60 kDa prolactin variant secreted by cervical cancer cells modulates apoptosis and cytokine production

Annie Riera Leal

Oncology Reports

View PDFchevron_right

Effects of 60�kDa prolactin and estradiol on metabolism and cell survival in cervical cancer: Co‑expression of their hormonal receptors during cancer progression

Annie Riera Leal

Oncology Reports

View PDFchevron_right

Biological Significance of Prolactin in Gynecologic Cancers

Anna Lokshin, Vera Levina

Cancer Research, 2009

View PDFchevron_right

The role of prolactin in human breast cancer Review

Hamza Mujagic

Biochemia Medica

View PDFchevron_right

Expression of Prolactin and Its Receptor in Human Breast Carcinoma 1

Jean-jacques Lebrun

Endocrinology, 1997

View PDFchevron_right

Increased Expression of Prolactin Receptor Gene Assessed by Quantitative Polymerase Chain Reaction in Human Breast Tumors Versus Normal Breast Tissues

Jean-françois Martini

The Journal of Clinical Endocrinology & Metabolism, 1998

View PDFchevron_right

Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation

Vincent Goffin

Oncogene, 2000

View PDFchevron_right

Prolactin receptor expression in gynaecomastia and male breast carcinoma

Mariana Mesquita

Histopathology, 2008

View PDFchevron_right

Involvement of prolactin in breast cancer: redefining the molecular targets11Abbreviations: PRL, prolactin; PRLR, PRL receptor; GH, growth hormone; JAK, Janus kinase; STAT, signal transducer and activator of transcription; MAPK, Mitogen–activated protein kinase; PI 3-K, Phosphoinositide 3-kinase;...

Vincent Goffin

Experimental Gerontology, 2000

View PDFchevron_right

Prolactin acts as a potent survival factor for human breast cancer cell lines

Jeff Holly

British journal of cancer, 2004

View PDFchevron_right

Expression of Progesterone Receptor A as an Independent Negative Prognosticator for Cervical Cancer

Vincent Cavailles

International Journal of Molecular Sciences

View PDFchevron_right

Stabilization of prolactin receptor in breast cancer cells

Natalie Minkovsky

Oncogene, 2005

View PDFchevron_right

Activation of the unliganded estrogen receptor by prolactin in breast cancer cells

Ana Aranda

Oncogene, 2009

View PDFchevron_right

Estradiol stimulates expression of two human prolactin receptor isoforms with alternative exons-1 in T47D breast cancer cells

Maria Dufau

The Journal of steroid biochemistry and molecular biology, 2002

View PDFchevron_right

Should prolactin be reconsidered as a therapeutic target in human breast cancer?

Vincent Goffin

Molecular and Cellular Endocrinology, 1999

View PDFchevron_right

Essential role of endogenous prolactin and cdk7 in estrogen-induced upregulation of the prolactin receptor in breast cancer cells

Maria Dufau

Oncotarget, 2017

View PDFchevron_right

The role of prolactin in human breast cancer

Hamza Mujagic

2009

View PDFchevron_right

Regulation of bcl-2 gene expression in human breast cancer cells by prolactin and its antagonist, hPRL-G129R

Susan Peirce

Oncogene, 2002

View PDFchevron_right

Antiapoptotic Effects of Estrogen In Normal and Cancer Human Cervical Epithelial Cells

Ying-Hong Feng

Endocrinology, 2004

View PDFchevron_right

The Exogenous Estrogen Antiproliferaive Effects On Cervical Cancer Cell Line: An In Vitro Study

Milad Kheirvari

2016

View PDFchevron_right

Suppression of Breast Cancer by Small Molecules That Block the Prolactin Receptor

Eric Hugo

Cancers

View PDFchevron_right

The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology

Davide Menafra

Frontiers in Endocrinology, 2020

View PDFchevron_right

Impaired Turnover of Prolactin Receptor Contributes to Transformation of Human Breast Cells

A. Plotnikov

Cancer Research, 2009

View PDFchevron_right

Interaction between 17β-estradiol, prolactin and human papillomavirus induce E6/E7 transcript and modulate the expression and localization of hormonal receptors

MARGARITA MONTOYA BUELNA

Cancer Cell International, 2019

View PDFchevron_right

The Expression of Prolactin Receptors in Benign Breast Tumors Is Not Associated with Serum Prolactin Level

Roman Moskalenko

Journal of Clinical Medicine, 2021

View PDFchevron_right

Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas

Erika Michel, Iris Reichler

BMC Veterinary Research, 2012

View PDFchevron_right

Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells

M. Shehata

2005

View PDFchevron_right

Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer

Lisa Arendt

Breast Cancer Research, 2011

View PDFchevron_right

Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5

Maria Dufau

Oncotarget, 2014

View PDFchevron_right

Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions

James Kench

Oncogene, 2007

View PDFchevron_right

Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness

Maria Dufau

Frontiers in Endocrinology

View PDFchevron_right

Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix

Ikuo Konishi

Cancer, 1991

View PDFchevron_right

The Survival Effect of Prolactin on PC3 Prostate Cancer Cells

Aiman Alsakkaf

European Urology, 2003

View PDFchevron_right

Prolactin and human breast cancer: a review

tvrtko bosnic

European Journal of Cancer, 1979

View PDFchevron_right

mPRs represent a novel target for PRL inhibition in experimental prolactinomas

SILVINA GUTIERREZ

Endocrine-Related Cancer, 2019

View PDFchevron_right